Safe anticoagulation with danaparoid in pregnancy and lactation

Thrombosis and Haemostasis

Volumn 92, Issue 1, 2004, Pages 211-

  Schindewolf, Marc ^a   Mosch, Gerlinde ^a   Bauersachs, Rupert M ^a   Lindhoff Last, Edelgard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DANAPAROID; HEPARIN;

ADULT; ANTICOAGULATION; BLEEDING; BREAST FEEDING; BREAST MILK; CASE REPORT; CAUCASIAN; CHILDBIRTH; DEEP VEIN THROMBOSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; LACTATION; MATERNAL BLOOD; NOTE; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 3542999891     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613643     Document Type: Note

References (5)

1. Lindhoff-Last E, Bauersachs R. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation. Semin Thromb Hemost 2002; 28(5): 439-46.
2. Greinacher A, Eckhardt T, Mussmann J, et al. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172). Thromb Res 1993; 71(2): 123-6.
3. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1998; 114(5 Suppl): 524-530S.
4. Harrison SJ, Rafferty I, McColl MD. Management of heparin allergy during pregnancy with danaparoid. Blood Coagul Fibrinolysis 2001; 12: 157-9.
5. Peeters LL, Hobbelen PM, Verkeste LL, et al. Placental transfer of Org 10172, a low-molecular weight heparinoid, in the awake late-pregnant guinea pig. Thromb Res 1986; 44(3): 277-83.